Two Sigma Investments LP Increases Position in TriMas Co. (NASDAQ:TRS)

Two Sigma Investments LP increased its position in TriMas Co. (NASDAQ:TRS - Free Report) by 8.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 134,580 shares of the industrial products company's stock after acquiring an additional 10,210 shares during the period. Two Sigma Investments LP owned about 0.33% of TriMas worth $3,309,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in TriMas by 3.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company's stock worth $568,000 after purchasing an additional 834 shares during the period. Sterling Capital Management LLC boosted its holdings in TriMas by 815.5% in the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock worth $32,000 after buying an additional 1,158 shares during the period. MetLife Investment Management LLC boosted its holdings in TriMas by 5.9% in the 4th quarter. MetLife Investment Management LLC now owns 24,788 shares of the industrial products company's stock worth $610,000 after buying an additional 1,378 shares during the period. State of Wyoming purchased a new stake in TriMas in the 4th quarter worth $50,000. Finally, Price T Rowe Associates Inc. MD lifted its stake in TriMas by 10.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,993 shares of the industrial products company's stock worth $689,000 after purchasing an additional 2,703 shares in the last quarter. Institutional investors own 99.42% of the company's stock.

TriMas Price Performance

Shares of NASDAQ TRS traded up $0.47 during mid-day trading on Tuesday, hitting $26.37. 305,990 shares of the company's stock traded hands, compared to its average volume of 334,908. The company's 50-day moving average is $23.31 and its two-hundred day moving average is $24.02. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The company has a market capitalization of $1.07 billion, a P/E ratio of 41.20 and a beta of 0.58. TriMas Co. has a 1 year low of $19.33 and a 1 year high of $28.51.

TriMas (NASDAQ:TRS - Get Free Report) last announced its earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.03. The firm had revenue of $241.67 million for the quarter, compared to analysts' expectations of $235.41 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business's revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.37 EPS. On average, equities analysts anticipate that TriMas Co. will post 1.69 EPS for the current fiscal year.

TriMas Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 13th. Stockholders of record on Tuesday, May 6th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date was Tuesday, May 6th. TriMas's dividend payout ratio (DPR) is presently 20.78%.

Insider Transactions at TriMas

In related news, CFO Scott A. Mell sold 2,218 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $22.54, for a total value of $49,993.72. Following the completion of the transaction, the chief financial officer now owns 26,288 shares of the company's stock, valued at $592,531.52. The trade was a 7.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Shawn Sedaghat purchased 72,937 shares of the business's stock in a transaction on Thursday, May 22nd. The stock was purchased at an average cost of $26.16 per share, for a total transaction of $1,908,031.92. Following the completion of the acquisition, the director now directly owns 1,883,758 shares of the company's stock, valued at approximately $49,279,109.28. The trade was a 4.03% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 1,770,195 shares of company stock valued at $43,736,754. 14.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. BWS Financial reiterated a "buy" rating and issued a $40.00 price target on shares of TriMas in a research note on Wednesday, April 30th. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.